Healthcare Cost and Resource Utilization Related to Metastatic Renal Cell Carcinoma Treatment With Intravenous and Oral Agents

NCT02928263 · clinicaltrials.gov ↗
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Business objectives have changed

Conditions

Interventions

Sponsor

Bristol-Myers Squibb